Robert W. Frelick
About
In The Last Decade
Robert W. Frelick
17 papers receiving 713 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 500
- Cancer Research 418
- Pulmonary and Respiratory Medicine 159
- Pathology and Forensic Medicine 158
- Surgery 112
Countries citing papers authored by Robert W. Frelick
This map shows the geographic impact of Robert W. Frelick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Frelick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Frelick more than expected).
Fields of papers citing papers by Robert W. Frelick
This network shows the impact of papers produced by Robert W. Frelick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Frelick. The network helps show where Robert W. Frelick may publish in the future.
Co-authorship network of co-authors of Robert W. Frelick
This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Frelick. A scholar is included among the top collaborators of Robert W. Frelick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Frelick. Robert W. Frelick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | SES discrepancies and Delaware cancer death rates. | 0 |
| 4 | 16 | |
| 5 | Results of a national survey of characteristics of hospital tumor conferences. | 23 |
| 6 | 13 | |
| 7 | Cancer and leukemia group B (CALGB). | 10 |
| 8 | 6 | |
| 9 | 32 | |
| 10 | 117 | |
| 11 | 27 | |
| 12 | 13 | |
| 13 | L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer breakdown → | 560 |
| 14 | Low dose therapy of hyperthyroidism. | 1 |
| 15 | Myleran treatment of chronic granulocytic leukemia. | 1 |
| 16 | Pneumothorax; a complication of neck surgery. | 1 |
| 17 | Abdominal aortic thrombosis producing a Goldblatt kidney. | 3 |
| 18 | Treatment complications in a case of lymphatic leukemia with secondary hemolytic anemia. | 1 |
| 19 | 9 | |
| 20 | Spontaneous hemopneumothorax; new concepts in treatment. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.